British journal of haematology

Rank: Unranked / 33517

Indexings	scopus ncbi ulakbim sci
Short Name	Br J Haematol
Abbreviated Name	british journal of haematology
ISSN	1365-2141
Aim and Scope
URL
Author Instructions

Journal Metrics & Performance

Journament Score: Calculating...

Metrics for this journal are being calculated. This may take some time for comprehensive analysis.

Publications Per Year

Recent Articles (11 total)

2015

Prognostic factors of early death in a cohort of 162 adult haemophagocytic syndrome: impact of triggering disease and early treatment with etoposide

Arca M;Fardet L;Galicier L;Rivière S;Marzac C;Aumont C;Lambotte O;Coppo P;;

Vol. 168 , No. 1 , pp. -

354 views Abstract

2020

Analysis of saliva samples and cluster of differentiation 3 (CD3)+ lymphocytes as a source of germline DNA in myeloproliferative neoplasms.

Garcia-Gisbert, Nieves;Camacho, Laura;Fernández-Ibarrondo, Lierni;Fernández-Rodriguez, Concepcion;Longarón, Raquel;Gibert, Joan;Angona, Anna;Andrade-Campos, Marcio;Salar, Antonio;Besses, Carlos;Bellosillo, Beatriz;

346 views DOI

2020

Red cell transfusion in outpatients with myelodysplastic syndromes: a feasibility and exploratory randomised trial.

Stanworth, Simon J;Killick, Sally;McQuilten, Zoe K;Karakantza, Marina;Weinkove, Robert;Smethurst, Heather;Pankhurst, Laura A;Hodge, Renate L;Hopkins, Valerie;Thomas, Helen L;Deary, Alison J;Callum, Jeannie;Lin, Yulia;Wood, Erica M;Buckstein, Rena;Bowen, David;, ;

296 views DOI Abstract

2019

Low-dose methotrexate: potential clinical impact on haematological and constitutional symptoms in myeloproliferative neoplasms.

Francis, Sebastian;Thomas, Sally;Luben, Robert;Sousos, Nikolaos;Mead, Adam;Snowden, John A;Zeidler, Martin P;

277 views DOI

2019

A journey through infectious risk associated with ruxolitinib.

Sant'Antonio, Emanuela;Bonifacio, Massimiliano;Breccia, Massimo;Rumi, Elisa;

Vol. 187 , No. 3 , pp. 286-295

272 views DOI Abstract

1999

Rabbit antithymocyte globulin (r-ATG) plus cyclosporine and granulocyte colony stimulating factor is an effective treatment for aplastic anaemia patients unresponsive to a first course of intensive immunosuppressive therapy

E. Di Bona,F. Rodeghiero,B. Bruno,A. Gabbas,P. Foa,A. Locasciulli,C. Rosanelli,L. Camba,P. Saracco,A. Lippi,A. P. Iori,F. Porta,V. De Rossi,B. Comotti,P. Iacopino,C. Dufour,A. Bacigalupo;E. Di Bona;F. Rodeghiero;B. Bruno;A. Gabbas;P. Foa;A. Locasciulli;C. Rosanelli;L. Camba;P. Saracco;A. Lippi;A. P. Iori;F. Porta;V. De Rossi;B. Comotti;P. Iacopino;C. Dufour;A. Bacigalupo;

Vol. 107 , No. 2 , pp. 330-334

239 views DOI Abstract

2020

Platelet biology of the rapidly failing lung.

Washington, A Valance;Esponda, Omar;Gibson, Angelia;

Vol. 188 , No. 5 , pp. 641-651

226 views DOI Abstract

2019

Efficacy and safety of a bortezomib and reduced-intensity cytarabine-based protocol, TMC ALLR1, for relapsed childhood ALL in India

Roy, P.

, pp. 0-0

226 views DOI